When was Magstim founded?

Magstim was founded in 1990 and raised its 1st funding round 25 years after it was founded.

Where is Magstim located?

Magstim is headquartered in Whitland, United Kingdom. It is registered at Spring Gardens, Whitland, Carmarthenshire, SA34 0HR.

How many employees does Magstim have?

As of Dec 31, 2023, the latest employee count at Magstim is 87.

Is Magstim a funded company?

Magstim is a funded company, having raised a total of $***** in its 1st and only funding round, a Unattributed round on Oct 02, 2015.

When was the latest funding round of Magstim?

Magstim's latest funding was a $***** Unattributed round on Oct 02, 2015, with participation from 0 investor. Its primary sector is Neurology. Globally, the Neurology sector has seen $1.37B in funding in 2026 to date.

What is the annual revenue of Magstim?

Annual revenue of Magstim is £9.4M as on Dec 31, 2023.

Where does Magstim rank among its competitors?

Magstim ranks 4th amongst 15 active competitors, of which 4 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was NeuroQore, which secured $1.51M in Jul, 2025.

Who are the top competitors of Magstim?

Magstim's top competitors include NeuroStar, Flow Neuroscience and Magnus Medical. Among them, NeuroQore secured the most recent funding round in July, 2025.

Magstim - 2026 Company Profile, Team, Funding, Competitors & Financials

Magstim is an acquired company based in Whitland (United Kingdom), founded in 1990 by Reza Jalinous. It operates as a Developer of EEG, TMS, and tDCS neurotechnology solutions. Magstim has raised $32.1M in funding. The company has 15 active competitors, including 4 funded and 3 that have exited. Its top competitors include companies like NeuroStar, Flow Neuroscience and Magnus Medical.

Company Details

Developer of EEG, TMS, and tDCS neurotechnology solutions. It provides systems, sensors, and integrated solutions for research and clinical applications. These technologies are used to study and treat brain conditions. The company offers support and resources to researchers and clinicians. Its product portfolio includes portable and user-friendly devices.

Website: www.magstim.com/
Social
Email ID: *****@magstim.com
Phone Number: +44 **********
Registered Address: Spring Gardens, Whitland, Carmarthenshire, SA34 0HR

Key Metrics

Founded Year

1990

Location

Whitland, United Kingdom

Stage

Acquired

Total Funding

$32.1M in 1 round

Latest Funding Round

Unattributed, Oct 02, 2015, $*****

Investors

Telegraph Hill Partners & 2 more

Ranked

4^th among 15 active competitors

Annual Revenue

£9.4M as on Dec 31, 2023

Employee Count

87 as on Dec 31, 2023

Investment & Acquisitions

Electrical Geodesics & 1 more

Similar Companies

NeuroStar & 13 more

Exit Details

Acquired by Telegraph Hill Partners (Jun 01, 2015)

View Magstim's full profile

Magstim is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
The Magstim Company Ltd CIN: 2308367 , Germany, Active	Oct 23, 1988	$11.7M (As on Dec 31, 2023)	87 (As on Dec 31, 2023)
The Magstim Company Limited CIN: 2308367 , United Kingdom, Active	Oct 23, 1988	$18.7M (As on Dec 31, 2022)	87 (As on Dec 31, 2024)
MAGSTIM INC. CIN: 168987296 , United States, Active	Jul 02, 2020	-	-	-

Magstim got acquired by Telegraph Hill Partners on Jun 01, 2015. It was facilitated by Global M&A Partners.

Click here to take a look at Magstim's acquisition in detail

Magstim has raised a total funding of $32.1M over 1 round. Magstim has 3 institutional investors.

Here is the list of recent funding rounds of Magstim:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 02, 2015	4239358	Unattributed	5731926	1721697	6813143	3300472

Access funding benchmarks and valuations. Sign up today!

View details of Magstim's funding rounds and investors

The founders of Magstim is Reza Jalinous.

Here are the details of Magstim's key team members:

Reza Jalinous: Former Co-Founder of Magstim.

View details of Magstim's Founder profiles and Board Members

Magstim's employee count trend

Magstim has 87 employees as of Dec 23. The total employee count is 15.0% lower than what it was in Dec 22. Here is Magstim's employee count trend over the years:

Uncover Magstim's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Magstim include NeuroStar, Flow Neuroscience and Magnus Medical. Here is the list of Top 10 competitors of Magstim, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroStar 2003, Malvern (United States), Public	Provider of a non-drug non-invasive therapeutic devices for neurorehabilitation	$119M	Ascension Ventures, Quaker Partners Management ... & 14 others	67/100
2nd	Flow Neuroscience 2016, Malmo (Sweden), Series A	Provider of a wearable device for stress and anxiety management	$11.9M	Khosla Ventures, HAX & 6 others	61/100
3rd	Magnus Medical 2017, Burlingame (United States), Series B	Provider of non invasive neuromodulation system for depression treatment	$89M	Red Tree Venture Capital, JAZZ Venture Partners ... & 1 others	59/100
4th	Magstim 1990, Whitland (United Kingdom), Acquired	Developer of EEG, TMS, and tDCS neurotechnology solutions	$32.1M	Telegraph Hill Partners, 3i Group & 1 others	47/100
5th	Tonic 1991, Farum (Denmark), Unfunded	Manufacturer of transcranial magnetic stimulation (TMS) systems for research and treatment	-	-	39/100
6th	Brainsway 2003, Jerusalem (Israel), Public	Develoepr of noninvasive neurostimulation treatments for mental health disorders	-	Shavit Capital, Fnx & 3 others	36/100
7th	Neuroprex 2012, Santa Clara (United States), Seed	Developer of a wearable device to modulate tissue for neurological diseases	$50K	EIC Fund, Europa & 1 others	32/100
8th	Soterix Medical 2008, New York City (United States), Funding Raised	Neuromodulation and brain stimulation technology for neuropsychiatric and neurological disorders	-	NINDS, HHS	30/100
9th	NeuroQore 2012, Ottawa (Canada), Series A	Develops a monophasic repetitive transcranial magnetic stimulation (rTMS) system	$1.76M	IndieBio, Ontario Brain Institute & 1 others	27/100
10th	Axilum Robotics 2011, Strasbourg (France), Funding Raised	Developer of robot for assisting healthcare professionals	-	Inserm Transfert Initiative	26/100